
Engaging Members of African American and Latino Communities in Preventive HIV Vaccine Trials
Author(s) -
Magdalena E. Sobieszczyk,
Guozhen Xu,
Krista B. Goodman,
Debbie Lucy,
Beryl A. Koblin
Publication year - 2009
Publication title -
journal of acquired immune deficiency syndromes
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.162
H-Index - 157
eISSN - 1944-7884
pISSN - 1525-4135
DOI - 10.1097/qai.0b013e3181990605
Subject(s) - hiv vaccine , medicine , human immunodeficiency virus (hiv) , african american , family medicine , virology , environmental health , immunology , vaccine trial , history , ethnology
African Americans (AAs) and Latinos in United States bear a disproportionate burden of HIV infection, yet remain underrepresented in HIV vaccine trials. The success in engaging and enrolling AAs and Latinos in phase 1 and phase 2 vaccine trials at 2 research sites in New York City is described.